Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
China flag China · Delayed Price · Currency is CNY
15.01
-0.54 (-3.47%)
May 21, 2026, 3:04 PM CST

SHE:300519 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
260.35265.13267.54270.28351.37320.77
Other Revenue
0.230.230.120.110.120.11
260.58265.36267.66270.4351.49320.88
Revenue Growth (YoY)
0.08%-0.86%-1.01%-23.07%9.54%13.35%
Cost of Revenue
152.54163.14177.89160.03169.81145.29
Gross Profit
108.04102.2289.77110.37181.68175.58
Selling, General & Admin
35.9838.2641.543.6450.6149.27
Research & Development
11.913.3512.6215.1315.5513.52
Other Operating Expenses
4.414.353.53.434.264.22
Operating Expenses
52.1455.7657.7461.5170.8666.85
Operating Income
55.946.4632.0348.87110.82108.73
Interest & Investment Income
9.6516.7623.5522.9814.0923.03
Other Non Operating Income (Expenses)
-0.01-0.01-0.01-0.02-0.01-0.01
EBT Excluding Unusual Items
65.5463.255.5771.83124.9131.74
Gain (Loss) on Sale of Assets
--0-0.07-0.29--0.71
Asset Writedown
0.16-0.04-0.010.020-0.02
Other Unusual Items
0.040.271.511.60.70.95
Pretax Income
65.7463.4357.0173.16125.6131.96
Income Tax Expense
9.79.226.628.816.7817.68
Net Income
56.0454.2150.3964.36108.82114.28
Net Income to Common
56.0454.2150.3964.36108.82114.28
Net Income Growth
7.56%7.58%-21.70%-40.86%-4.78%15.46%
Shares Outstanding (Basic)
160159163161160161
Shares Outstanding (Diluted)
160159163161160161
Shares Change (YoY)
-1.81%-1.91%1.03%0.54%-0.58%0.83%
EPS (Basic)
0.350.340.310.400.680.71
EPS (Diluted)
0.350.340.310.400.680.71
EPS Growth
9.54%9.68%-22.50%-41.18%-4.23%14.52%
Free Cash Flow
76.2165.4548.2337.3109.78127.64
Free Cash Flow Per Share
0.480.410.300.230.690.79
Dividend Per Share
0.3000.3000.3000.4000.5000.600
Dividend Growth
---25.00%-20.00%-16.67%-
Gross Margin
41.46%38.52%33.54%40.82%51.69%54.72%
Operating Margin
21.45%17.51%11.97%18.07%31.53%33.88%
Profit Margin
21.50%20.43%18.83%23.80%30.96%35.62%
Free Cash Flow Margin
29.25%24.66%18.02%13.80%31.23%39.78%
EBITDA
70.5961.246.9763.64124.88121.59
EBITDA Margin
27.09%23.06%17.55%23.54%35.53%37.89%
D&A For EBITDA
14.6914.7414.9314.7714.0512.86
EBIT
55.946.4632.0348.87110.82108.73
EBIT Margin
21.45%17.51%11.97%18.07%31.53%33.88%
Effective Tax Rate
14.76%14.53%11.61%12.03%13.36%13.40%
Revenue as Reported
260.58265.36267.66270.4351.49320.88
Source: S&P Global Market Intelligence. Standard template. Financial Sources.